Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

NCT05662943 · clinicaltrials.gov ↗

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Polypoidal Choroidal Vasculopathy
Choroidal Neovascularization
Age-Related Macular Degeneration

Interventions

DRUG: Intravitreal aflibercept injection

Sponsor

Kim's Eye Hospital